$3.42
0.061.79%
At close: -
$3.48
0.061.75%
After Hours: Jan 17, 5:01 PM EDT
Comments
Loading...
Alterity Therapeutics (ATHE) Forecast
NewsEarningsAlterity Therapeutics (ATHE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAlterity Therapeutics (NASDAQ:ATHE) Stock Quotes, Forecast and News Summary
Alterity Therapeutics Stock (NASDAQ: ATHE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alterity Therapeutics (ATHE) stock?
You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.
Who are Alterity Therapeutics (ATHE) competitors?
Other companies in Alterity Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS), Palatin Techs (AMEX:PTN) and Longeveron (NASDAQ:LGVN).
What is the forecast, or price target, for Alterity Therapeutics (ATHE) stock?
Alterity Therapeutics has a consensus price target of $6.25.
What is the current price for Alterity Therapeutics (ATHE)?
The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $3.48 last updated January 17, 2025 at 5:01 PM EST.
Does Alterity Therapeutics (ATHE) pay a dividend?
There are no upcoming dividends for Alterity Therapeutics.
When is Alterity Therapeutics (NASDAQ:ATHE) reporting earnings?
Alterity Therapeutics does not have any upcoming earnings scheduled.
Is Alterity Therapeutics (ATHE) going to split?
There is no upcoming split for Alterity Therapeutics.
What sector and industry does Alterity Therapeutics (ATHE) operate in?
Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.